NEW YORK, Sept. 09, 2016 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Middle District of Tennessee on behalf of investors who purchased Corrections Corporation of America (NYSE:CXW) securities between February 27, 2012 and August 17, 2016.
Click here to learn about the case: http://www.wongesq.com/pslra/corrections-corporation-of-america. There is no cost or obligation to you.
According to the complaint, the Company made false and/or misleading statements and/or failed to disclose: (a) that Corrections Corporation’s facilities lacked adequate safety and security standards and were less efficient at offering correctional services than the Federal Bureau of Prisons’ (“BOP”) facilities; (b) that the Company’s rehabilitative services for inmates were less effective than the BOP’s services; (c) that the U.S. Department of Justice (“DOJ”) was unlikely to renew and/or extend its contracts with Corrections Corporation; (d) and that as a result of the above, Corrections Corporation’s public statements were materially false and misleading at all relevant times.
On August 18, 2016, the DOJ announced that it has decided to stop using private prisons, since they are less safe and less effective than federal government-run prisons.
If you suffered a loss in Corrections Corporation you have until October 24, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/corrections-corporation-of-america.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]


Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
Shell M&A Chief Exits After BP Takeover Proposal Rejected
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing 



